Journey Medical Corp Revenue 2020–2025
Journey Medical Corp annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Journey Medical Corp revenue for the quarter ending March 31, 2026 was 15.9 M, a 21.17% increase year-over-year.
- Journey Medical Corp revenue for the twelve months ending March 31, 2026 was 61.1 M, a 5.71% increase year-over-year.
- Journey Medical Corp annual revenue for 2025 was 61.2 M, a 11.07% increase from 2024.
- Journey Medical Corp annual revenue for 2024 was 55.1 M, a 7.59% decrease from 2023.
- Journey Medical Corp annual revenue for 2023 was 59.7 M, a 15.96% decrease from 2022.
- Journey Medical Corp annual revenue for 2022 was 71.0 M.
Journey Medical Corp (DERM) — Frequently Asked Questions
Journey Medical Corp (DERM) is a publicly traded US company. It has a market capitalization of $149M. In fiscal 2025 it reported revenue of $61M and net income of -$11M. Explore DERM's stock price, financial statements, earnings history, margins and key ratios below.
What is Journey Medical Corp's market cap?
Journey Medical Corp (DERM) has a market capitalization of $149M.
What is the DERM stock price?
DERM trades at $6.07 (-1.78% on the day).
How much revenue does Journey Medical Corp make?
Journey Medical Corp reported revenue of $61M in fiscal 2025.
Is DERM profitable?
In fiscal 2025, Journey Medical Corp reported net income of -$11M.